Managing potassium to optimize therapy in heart failure

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Innovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
Innovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
CME/CE
Innovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
0.25 credits
- Riccardo Maria Inciardi, MD, PhD
0.25 credits
Changing disease characteristics of cardiac amyloidosis
Changing disease characteristics of cardiac amyloidosis
ESC Heart Failure 2025
Changing disease characteristics of cardiac amyloidosis
- Peter-Paul Zwetsloot, MD, PhD
Uptake of GDMT in HFrEF: from prescriptions to patient adherence and persistence
Uptake of GDMT in HFrEF: from prescriptions to patient adherence and persistence
ESC Heart Failure 2025
Uptake of GDMT in HFrEF: from prescriptions to patient adherence and persistence
- Felix Lindberg, MD, PhD
Greater reductions in NT-proBNP with dapagliflozin/spironolactone combination therapy in HFmrEF/HFpEF
Greater reductions in NT-proBNP with dapagliflozin/spironolactone combination therapy in HFmrEF/HFpEF
ESC Heart Failure 2025
Greater reductions in NT-proBNP with dapagliflozin/spironolactone combination therapy in HFmrEF/HFpEF
- João Pedro Ferreira, MD, PhD